Xiangcheng Li, Changxian Li, Yuan Cheng, Bin Zhang, Yonghua Xu. "A phase 2, randomized, multicenter study of adjuvant adebrelimab plus capecitabine in resected cholangiocarcinoma with high-risk factors: ACHIEVE.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps4220